Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides

Despite more than 25 years of research, the molecular targets of quinoline-3-carboxamides have been elusive although these compounds are currently in Phase II and III development for treatment of autoimmune/inflammatory diseases in humans. Using photoaffinity cross-linking of a radioactively labelled quinoline-3-carboxamide compound, we could determine a direct association between human S100A9 and quinoline-3-carboxamides. This interaction was strictly dependent on both Zn++ and Ca++. We also show that S100A9 in the presence of Zn++ and Ca++ is an efficient ligand of receptor for advanced glycation end products (RAGE) and also an endogenous Toll ligand in that it shows a highly specific interaction with TLR4/MD2. Both these interactions are inhibited by quinoline-3-carboxamides. A clear structure-activity relationship (SAR) emerged with regard to the binding of quinoline-3-carboxamides to S100A9, as well as these compounds potency to inhibit interactions with RAGE or TLR4/MD2. The same SAR was observed when the compound's ability to inhibit acute experimental autoimmune encephalomyelitis in mice in vivo was analysed. Quinoline-3-carboxamides would also inhibit TNFα release in a S100A9-dependent model in vivo, as would antibodies raised against the quinoline-3-carboxamide–binding domain of S100A9. Thus, S100A9 appears to be a focal molecule in the control of autoimmune disease via its interactions with proinflammatory mediators. The specific binding of quinoline-3-carboxamides to S100A9 explains the immunomodulatory activity of this class of compounds and defines S100A9 as a novel target for treatment of human autoimmune diseases.

• Publication year

  2009

• Venue

  PLoS Biology

• Publication date

  2009-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1371/journal.pbio.1000097PMID 19402754PMCID 2671563
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.

  2008cited by this paper
• Divalent metal ion complexes of S100B in the absence and presence of pentamidine.

  2008cited by this paper
• S100 proteins expressed in phagocytes: a novel group of damage‐associated molecular pattern molecules

  2007cited by this paper
• Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock

  2007influential reference
• Hexameric Calgranulin C (S100A12) Binds to the Receptor for Advanced Glycated End Products (RAGE) Using Symmetric Hydrophobic Target-binding Patches*

  2006cited by this paper
• Biophysical characterization of S100A8 and S100A9 in the absence and presence of bivalent cations.

  2006cited by this paper
• Alarmins: chemotactic activators of immune responses.

  2005cited by this paper
• Treatment with laquinimod reduces development of active MRI lesions in relapsing MS

  2005cited by this paper
• A designed TLR4/MD-2 complex to capture LPS

  2005cited by this paper
• S100A8 and S100A9 in Human Arterial Wall

  2005cited by this paper
• Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells.

  2005cited by this paper
• MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes.

  2004cited by this paper
• Proinflammatory S100 proteins in arthritis and autoimmune disease.

  2004influential reference
• Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship.

  2004cited by this paper
• S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature).

  2004cited by this paper
• Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules.

  2003cited by this paper
• Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system

  2003cited by this paper
• Absence of S100A12 in mouse: implications for RAGE-S100A12 interaction.

  2003cited by this paper
• Loss of S100A9 (MRP14) Results in Reduced Interleukin-8-Induced CD11b Surface Expression, a Polarized Microfilament System, and Diminished Responsiveness to Chemoattractants In Vitro

  2003cited by this paper
• The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis.

  2002cited by this paper
• The S100 Family Heterodimer, MRP-8/14, Binds with High Affinity to Heparin and Heparan Sulfate Glycosaminoglycans on Endothelial Cells*

  2002cited by this paper
• S100 proteins: structure, functions and pathology.

  2002cited by this paper
• Linomide in relapsing and secondary progressive MS

  2000cited by this paper
• Linomide in relapsing and secondary progressive MS

  2000cited by this paper
• A null mutation in the inflammation-associated S100 protein S100A8 causes early resorption of the mouse embryo.

  1999cited by this paper
• RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides.

  1999cited by this paper
• High Level Expression and Dimer Characterization of the S100 EF-hand Proteins, Migration Inhibitory Factor-related Proteins 8 and 14*

  1998cited by this paper
• Low dose linomide in Type I juvenile diabetes of recent onset: a randomised placebo-controlled double blind trial

  1998cited by this paper
• The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils.

  1998cited by this paper
• Treatment of secondary progressive multiple sclerosis with the immunomodulator linomide

  1996cited by this paper
• Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosis

  1996cited by this paper
• Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosis

  1996cited by this paper
• Phosphorylation of MRP14, an S100 protein expressed during monocytic differentiation, modulates Ca(2+)-dependent translocation from cytoplasm to membranes and cytoskeleton.

  1996cited by this paper
• The expanding role of quantitative structure-activity relationships (QSAR) in toxicology.

  1995cited by this paper
• Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide).

  1993cited by this paper
• Linomide, a novel immunomodulator that prevents death in four models of septic shock

  1993cited by this paper
• The biochemical basis of zinc physiology.

  1993cited by this paper
• lonomycin-regulated phosphorylation of the myeloid calcium-binding protein p14

  1989cited by this paper
• Paradoxical effects of LS-2616 (Linomide) treatment in the type II collagen arthritis model in mice

  1989cited by this paper
• Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis

  1987cited by this paper
• Effects of LS-2616 administration upon the autoimmune disease of (NZB x NZW) F1 hybrid mice.

  1986cited by this paper
• A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids.

  1984cited by this paper
• Hemostasis, Thrombosis, and Vascular Biology Mrp8/mrp14 Impairs Endothelial Integrity and Induces a Caspase-dependent and -independent Cell Death Program Materials and Methods Kinetics of Mrp8/mrp14-induced Ec Death Table 1. Apoptosis-and Cell-cycle-related Genes Differentially Regulated by Mrp8/mrp

  year unknowncited by this paper

• The S100A8/A9 complex promotes food intake and prevents adipose tissue loss during cancer cachexia in mice.

  2026cites this paper
• Myeloid-derived suppressor cells promote therapy-induced resistance in prostate cancer.

  2026cites this paper
• A new strategy for inflammatory regulation in sepsis: mechanisms and clinical progress of hemoperfusion techniques in correcting inflammatory homeostasis in sepsis.

  2026cites this paper
• S100A9 as a potential novel target for neuromyelitis optica spectrum disorder.

  2025cites this paper
• Development of novel neutralizing single-chain fragment variable antibodies against S100A8

  2025cites this paper
• Innate immune mechanisms hijacked by leukemia-initiating stem cells for selective advantage and immune evasion in Ptpn11-associated JMML

  2025cites this paper
• Neutralizing IL-22RA1 improves histological and molecular alterations associated with atopic dermatitis pathogenesis.

  2025cites this paper
• S100A8 and S100A9-mediated keratinocyte affecting T lymphocyte immune imbalance through TLR4/NF-κ B in psoriasis.

  2025cites this paper
• Potential diagnostic markers and therapeutic targets for DM2 and periodontitis based on bioinformatics analysis

  2025cites this paper
• Neutrophil–Endothelium Interaction Mediated by S100A9 Promotes Pulmonary Vascular Remodeling During Pulmonary Hypertension

  2025cites this paper
• The roles of S100A8/A9 and S100A12 in autoimmune diseases: Mechanisms, biomarkers, and therapeutic potential.

  2025cites this paper
• Zebrafish do not have a calprotectin ortholog

  2025cites this paper
• The role of calprotectin in vascular calcification

  2025cites this paper
• Targeting S100A9-mediated inflammation: a novel therapeutic approach for CLL

  2025cites this paper
• Exploring the Relevance of S100A8 and S100A9 Proteins in Preeclampsia: A Narrative Review

  2025influential citation
• S100A8/A9 Inhibition Reduces Splenic Myelopoiesis and Improves Outcomes After Stroke

  2025cites this paper
• Inflammatory disease progression shapes nanoparticle biomolecular corona-mediated immune activation profiles

  2025cites this paper
• Targeting the S100A9/P38 MAPK/HSPB1 axis as a novel approach for aortic dissection therapy.

  2025cites this paper
• Suppression of the neutrophil-derived S100A8/A9 complex ameliorates doxorubicin-induced cardiomyopathy in non-human primates.

  2025cites this paper
• S100A8/A9 innate immune signaling as a distinct mechanism driving progression of smoking-related breast cancers

  2025cites this paper
• Correlation of serum calprotectin with outcome of acute cerebral infarction

  2025cites this paper
• Identification and Preliminary Characterization of a Novel Tasquinimod Analog that Unexpectedly Induces Mitotic Arrest by Alteration of Microtubule Dynamics.

  2025cites this paper
• Infant Viability in Severe Preeclampsia: Management Strategies and the Potential Role of Calprotectin—A Narrative Review

  2025cites this paper
• Elevated levels of S100A8 and S100A9 exacerbate muscle mitochondrial fragmentation in sepsis-induced muscle atrophy

  2025cites this paper
• Saffron as a Promising Therapy for Inflammatory Bowel Disease

  2024cites this paper
• Advances in the study of S100A9 in cardiovascular diseases

  2024cites this paper
• S100A9: The Unusual Suspect Connecting Viral Infection and Inflammation.

  2024cites this paper
• S100A9 interacts with a dynamic region on CD14 to activate Toll-like receptor 4

  2024cites this paper
• Nanoparticle-neutrophils interactions for autoimmune regulation.

  2024cites this paper
• S100a9 might act as a modulator of the Toll-like receptor 4 transduction pathway in chronic rhinosinusitis with nasal polyps

  2024cites this paper
• Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin Axis.

  2024cites this paper
• Computational Deciphering of the Role of S100A8 and S100A9 Proteins and Their Changes in the Structure Assembly Influences Their Interaction with TLR4, RAGE, and CD36

  2024cites this paper
• Multifaceted roles of neutrophils in tumor microenvironment.

  2024cites this paper
• Zebrafish do not have calprotectin

  2024cites this paper
• New approaches and prospects of immunotherapy and gene therapy for prostate cancer

  2024cites this paper
• Endogenous Ligands of TLR4 in Microglia: Potential Targets for Related Neurological Diseases.

  2024cites this paper
• High S100A9 level predicts poor survival, and the S100A9 inhibitor paquinimod is a candidate for treating idiopathic pulmonary fibrosis

  2024cites this paper
• Virtual Probing on the Influence of Ca2+ and Zn2+ Bound S100A8 and S100A9 Proteins Towards their Interaction Against Pattern Recognition Receptors Aggravating Rheumatoid Arthritis

  2024influential citation
• Anti-Inflammatory Effects of Extracellular Vesicles from Ecklonia cava on 12-O-Tetradecanoylphorbol-13-Acetate-Induced Skin Inflammation in Mice

  2024cites this paper
• Dysregulated S100A9 Expression Impairs Matrix Deposition in Chronic Wounds

  2024influential citation
• S100A9 regulates M1 macrophage polarization and exacerbates steatotic liver ischemia-reperfusion injury.

  2024cites this paper
• Retinal microglia-derived S100A9 incite NLRP3 inflammasome in a Western diet fed Ossabaw pig retina

  2024cites this paper
• Changing expression system alters oligomerization and proinflammatory activity of recombinant human S100A9

  2024cites this paper
• Calprotectin is regulated by IL-17A and induces steroid hyporesponsiveness in asthma

  2024cites this paper
• Adjunctive treatments for pneumococcal meningitis: a systematic review of experimental animal models

  2024cites this paper
• S100a8/A9 proteins: critical regulators of inflammation in cardiovascular diseases

  2024cites this paper
• Prototypical innate immune mechanism hijacked by leukemia-initiating mutant stem cells for selective advantage and immune evasion in Ptpn11-associated juvenile myelomonocytic leukemia

  2024cites this paper
• Blocking S100A9-signaling is detrimental to the initiation of anti-tumor immunity

  2024cites this paper
• mRNA expression profile reveals differentially expressed genes in splenocytes of experimental autoimmune encephalomyelitis model

  2023cites this paper
• S100 proteins in head and neck squamous cell carcinoma (Review)

  2023influential citation
• S100A9 is indispensable for survival of pneumococcal pneumonia in mice

  2023cites this paper
• Concerning the photophysics of fluorophores towards tailored bioimaging compounds: a case study involving S100A9 inflammation markers

  2023cites this paper
• S100A9 drives the chronification of psoriasiform inflammation by inducing IL-23/type 3 immunity.

  2023cites this paper
• Complex regulation of alarmins S100A8/A9 and secretion via Gasdermin-D pores exacerbates autoinflammation in Familial Mediterranean Fever.

  2023cites this paper
• S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes

  2023cites this paper
• S100A9 plays a key role in Clostridium perfringens beta2 toxin-induced inflammatory damage in porcine IPEC-J2 intestinal epithelial cells

  2023cites this paper
• Decreased S100A9 expression alleviates Clostridium perfringens beta2 toxin-induced inflammatory injury in IPEC-J2 cells

  2023cites this paper
• Deficiency of S100 calcium binding protein A9 attenuates vascular dysfunction in aged mice

  2023cites this paper
• S100A8/A9 is a valuable biomarker and treatment target to detect and modulate neutrophil involvement in myocardial infarction

  2023cites this paper
• Endothelial Damage Arising From High Salt Hypertension Is Elucidated by Vascular Bed Systematic Profiling

  2023cites this paper
• Calprotectin blockade inhibits long-term vascular pathology following peritoneal dialysis-associated bacterial infection

  2023cites this paper
• Single-cell transcriptome profiling of sepsis identifies HLA-DRlowS100Ahigh monocytes with immunosuppressive function

  2023cites this paper
• Targeting activin receptor–like kinase 7 ameliorates adiposity and associated metabolic disorders

  2023influential citation
• Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction

  2023cites this paper
• A proteome-wide screen identifies the calcium binding proteins, S100A8/S100A9, as clinically relevant therapeutic targets in aortic dissection.

  2023cites this paper
• Inhibition of TLR4 signalling to dampen joint inflammation in osteoarthritis

  2023cites this paper
• Single-cell RNA sequencing unveils the communications between malignant T and myeloid cells contributing to tumor growth and immunosuppression in cutaneous T-cell lymphoma.

  2022cites this paper
• Pathogenic roles of neutrophil‐derived alarmins (S100A8/A9) in heart failure: From molecular mechanisms to therapeutic insights

  2022cites this paper
• S100 Proteins as Novel Therapeutic Targets in Psoriasis and Other Autoimmune Diseases

  2022cites this paper
• Gasdermin D-dependent platelet pyroptosis exacerbates NET formation and inflammation in severe sepsis

  2022cites this paper
• The Good and the Bad: Monocytes’ and Macrophages’ Diverse Functions in Inflammation

  2022cites this paper
• S100a9 Attenuates Inflammation during Repeated Social Defeat Stress

  2022cites this paper
• Low-Grade Inflammation in the Pathogenesis of Osteoarthritis: Cellular and Molecular Mechanisms and Strategies for Future Therapeutic Intervention

  2022cites this paper
• Polymorphisms of Calgranulin Genes and Ischemic Stroke in a Chinese Population

  2022cites this paper
• S100a9 Protects Against the Effects of Repeated Social Defeat Stress

  2022cites this paper
• IFN-induced protein with tetratricopeptide repeats 2 (Ifit2) limits autoimmune inflammation by regulating myeloid cell activation and metabolic activity

  2022cites this paper
• RAGE Inhibitors as Alternatives to Dexamethasone for Managing Cerebral Edema Following Brain Tumor Surgery

  2022cites this paper
• A Structural Perspective on Calprotectin as a Ligand of Receptors Mediating Inflammation and Potential Drug Target

  2022influential citation
• Hematopoietic progenitor cell liabilities and alarmins S100A8/A9‐related inflammaging associate with frailty and predict poor cardiovascular outcomes in older adults

  2022cites this paper
• Single Cell RNA Sequencing Identifies a Unique Inflammatory Macrophage Subset as a Druggable Target for Alleviating Acute Kidney Injury

  2022cites this paper
• Platelet Versus Megakaryocyte: Who Is the Real Bandleader of Thromboinflammation in Sepsis?

  2022cites this paper
• Neuroinflammation as an etiological trigger for depression comorbid with inflammatory bowel disease

  2022cites this paper
• Neutrophils as potential therapeutic targets in hepatocellular carcinoma

  2022cites this paper
• Overexpression of S100A9 in obesity impairs macrophage differentiation via TLR4-NFkB-signaling worsening inflammation and wound healing

  2022influential citation
• Tasquinimod efficacy and S100A9 expression in glucose-treated HREC cells

  2021cites this paper
• DSS-induced inflammation in the colon drives a proinflammatory signature in the brain that is ameliorated by prophylactic treatment with the S100A9 inhibitor paquinimod

  2021cites this paper
• A microRNA-21–mediated SATB1/S100A9/NF-κB axis promotes chronic obstructive pulmonary disease pathogenesis

  2021cites this paper
• S100A8/A9 in COVID-19 pathogenesis: Impact on clinical outcomes

  2021cites this paper
• Shuangxinfang Prevents S100A9-Induced Macrophage/Microglial Inflammation to Improve Cardiac Function and Depression-Like Behavior in Rats After Acute Myocardial Infarction

  2021cites this paper
• Investigation by top‐down high‐performance liquid chromatography–mass spectrometry of glutathionylation and cysteinylation of salivary S100A9 and cystatin B in preterm newborns

  2021cites this paper
• Role of proteins MRP8 (S100A8) and MRP14 (S100A9) in the development of critical condition in patients with pneumonia with A/H1N1 influenza

  2021cites this paper
• An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod

  2021cites this paper
• The S100 Protein Family as Players and Therapeutic Targets in Pulmonary Diseases

  2021influential citation
• Transcriptional Profiling and Functional Analysis of N1/N2 Neutrophils Reveal an Immunomodulatory Effect of S100A9-Blockade on the Pro-Inflammatory N1 Subpopulation

  2021cites this paper
• Serum calprotectin as a prognostic predictor in severe traumatic brain injury.

  2021cites this paper
• High Monocyte Count and Expression of S100A9 and S100A12 in Peripheral Blood Mononuclear Cells Are Associated with Poor Outcome in Patients with Metastatic Prostate Cancer

  2021cites this paper
• Glycolipid toxicity induces osteogenic dysfunction via the TLR4/S100B pathway.

  2021cites this paper
• Inhibitory Effect of Paquinimod on a Murine Model of Neutrophilic Asthma Induced by Ovalbumin with Complete Freund's Adjuvant

  2021cites this paper
• E-Selectin-Dependent Inflammation and Lipolysis in Adipose Tissue Exacerbate Steatosis-to-NASH Progression via S100A8/9

  2021cites this paper
• Discerning the promising binding sites of S100/calgranulins and their therapeutic potential in atherosclerosis

  2021influential citation